MEDGF (Medacta Group) Owner Earnings per Share (TTM): 6.87 (As of Dec. 2025) — 89% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEDGF Medacta Group SA MEDGF
82 GF Score
Price $160.00
GF Value $91.04
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Medacta Group Owner Earnings per Share (TTM)?

Medacta Group MEDGF +90.68% 82 Owner Earnings per Share (TTM) is 6.87 as of Dec. 2025, which is 89% below its 10-year median of 60.53. GuruFocus rates MEDGF with a GF Score™ of 82/100 and a GF Value™ of $91.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Medacta Group ranks better than 57.46% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medacta Group's Owner Earnings per Share (TTM) ended in Dec. 2025 was $6.87. It's Price-to-Owner-Earnings ratio for today is 23.29.


The historical rank and industry rank for Medacta Group's Owner Earnings per Share (TTM) or its related term are showing as below:

MEDGF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 23.28   Med: 60.53   Max: 195.89
Current: 23.28


During the past 11 years, the highest Price-to-Owner-Earnings ratio of Medacta Group was 195.89. The lowest was 23.28. And the median was 60.53.


MEDGF's Price-to-Owner-Earnings is ranked better than
57.46% of 315 companies
in the Medical Devices & Instruments industry
Industry Median: 27.42 vs MEDGF: 23.28

Medacta Group's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was $2.07. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $5.55. It's PE Ratio (TTM) ratio for today is 28.85.

Medacta Group's EPS without NRI for the six months ended in Dec. 2025 was $1.96. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $4.74. It's PE Ratio without NRI ratio for today is 33.75.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Medacta Group Owner Earnings per Share (TTM) Related Terms


Medacta Group Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Medacta Group's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medacta Group Owner Earnings per Share (TTM) Chart

Medacta Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 1.60 1.21 2.71 3.00

Medacta Group Semi-Annual Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 0.00 2.71 0.00 3.00

MEDGF vs ABT, SYK, MDT: Owner Earnings per Share (TTM) Comparison

For the Medical Devices subindustry, Medacta Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group Price-to-Owner-Earnings vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medacta Group's Price-to-Owner-Earnings falls into.


MEDGF
82GF Score
Medacta Group SA MEDGF
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medacta Group Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Medacta Group's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 111.8
Depreciation, Depletion and Amortization 87.1
Change In Deferred Tax 23.2
5Y Average of Maintenance Capital Expenditure 56.5
Change In Working Capital -21.0
Shares Outstanding (Diluted Average) 20.0

1. Start with "Net Income" from income statement. Medacta Group's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was $111.8 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Medacta Group's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2025 was $87.1 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Medacta Group's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 was $23.2 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $56.5 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Medacta Group's 5-Year Average Maintenance Capital Expenditure = $56.5 Mil

5. "Change In Working Capital" is from cashflow statement. Medacta Group's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2025 was $-21.0 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Medacta Group's Shares Outstanding (Diluted Average) for the months ended in Dec. 2025 was 19.972 Mil.

Medacta Group's Onwer Earnings Per Share for Dec. 2025 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 111.78 +87.138+23.222
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-56.472+-21.049)/19.972
=6.87

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=160.00/6.87
=23.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 6.87 mean?
Medacta Group (MEDGF) has a Owner Earnings per Share (TTM) of 6.87 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Medacta Group. This is 89% below median its historical median of 60.53. Over the past decade, Medacta Group's Owner Earnings per Share (TTM) has ranged from 23.28 to 195.89. According to the industry distribution chart, Medacta Group ranks #134 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 42.5%.
Is Medacta Group's Owner Earnings per Share (TTM) too high?
Medacta Group's current Owner Earnings per Share (TTM) of 6.87 is 89% below median its 10-year median of 60.53. Over the past 10 years, this metric has ranged from a low of 23.28 to a high of 195.89. The Medical Devices & Instruments industry median Owner Earnings per Share (TTM) is 27.42. Medacta Group's value of 6.87 is 74.9% below this industry median. Based on the distribution chart, Medacta Group ranks #134 out of 315 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medacta Group has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medacta Group's Owner Earnings per Share (TTM) compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medacta Group ranks #134 out of 315 companies for Owner Earnings per Share (TTM). This puts Medacta Group in the upper half of its industry. The industry median Owner Earnings per Share (TTM) is 27.42. Medacta Group's value of 6.87 is 74.9% below this benchmark. Historically, Medacta Group's own Owner Earnings per Share (TTM) has ranged from 23.28 to 195.89 over the past decade. While the company's 10-year median is 60.53 vs. the industry median of 27.42, Medacta Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Devices & Instruments company?
The median Owner Earnings per Share (TTM) among Medical Devices & Instruments companies is 27.42, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medacta Group's current Owner Earnings per Share (TTM) of 6.87 is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Medacta Group. For the Medical Devices & Instruments industry, the median Owner Earnings per Share (TTM) is 27.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medacta Group's current Owner Earnings per Share (TTM) is 6.87, which is 89% below median its own 10-year median of 60.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medacta Group stock overvalued right now?
Based on GuruFocus' analysis, Medacta Group (MEDGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $91.04, compared to a current price of $160.00 — trading 75.7% above its estimated fair value. The current Owner Earnings per Share (TTM) is 6.87, which is 89% below median its 10-year median of 60.53 and 74.9% below the Medical Devices & Instruments industry median of 27.42. Medacta Group's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Medacta Group (MEDGF), the current Owner Earnings per Share (TTM) is 6.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medacta Group (MEDGF) Overvalued in 2026?

Based on GuruFocus' analysis, Medacta Group stock appears to be overvalued. The current stock price of $160.00 is trading 75.7% above its estimated GF Value™ of $91.04. GuruFocus considers Medacta Group to be Significantly Overvalued.

Key valuation signals for MEDGF:

  • Owner Earnings per Share (TTM): 6.87 (89% below median its 10-year median of 60.53)
  • GF Value™: $91.04 vs. price of $160.00 (75.7% above fair value)
  • GF Score™: 82/100 with 3 warning signs
  • Industry Position: 74.9% below the Medical Devices & Instruments median (#134 of 315)

No single metric tells the full story. See the MEDGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medacta Group Business Description

Address Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
82GF Score

Get the complete analysis for MEDGF

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$160.00
Price
$91.04
GF Value